Acasti Pharma Inc. (CVE:ACST – Get Free Report) shares rose 1.8% during mid-day trading on Thursday . The company traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Up 1.8 %
The business has a fifty day simple moving average of C$0.58 and a 200-day simple moving average of C$0.58. The firm has a market cap of C$18.19 million, a P/E ratio of -1.21 and a beta of 1.22.
About Acasti Pharma
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
See Also
- Five stocks we like better than Acasti Pharma
- Stock Splits, Do They Really Impact Investors?
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Find and Profitably Trade Stocks at 52-Week Lows
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
